307 related articles for article (PubMed ID: 29991802)
1. Exposure of Barrett's and esophageal adenocarcinoma cells to bile acids activates EGFR-STAT3 signaling axis via induction of APE1.
Bhat AA; Lu H; Soutto M; Capobianco A; Rai P; Zaika A; El-Rifai W
Oncogene; 2018 Nov; 37(46):6011-6024. PubMed ID: 29991802
[TBL] [Abstract][Full Text] [Related]
2. APE1 redox function is required for activation of Yes-associated protein 1 under reflux conditions in Barrett's-associated esophageal adenocarcinomas.
Ballout F; Lu H; Chen L; Sriramajayam K; Que J; Meng Z; Wang TC; Giordano S; Zaika A; McDonald O; Peng D; El-Rifai W
J Exp Clin Cancer Res; 2022 Sep; 41(1):264. PubMed ID: 36045416
[TBL] [Abstract][Full Text] [Related]
3. APE1/Ref-1 regulates STAT3 transcriptional activity and APE1/Ref-1-STAT3 dual-targeting effectively inhibits pancreatic cancer cell survival.
Cardoso AA; Jiang Y; Luo M; Reed AM; Shahda S; He Y; Maitra A; Kelley MR; Fishel ML
PLoS One; 2012; 7(10):e47462. PubMed ID: 23094050
[TBL] [Abstract][Full Text] [Related]
4. Activation of NRF2 by APE1/REF1 is redox-dependent in Barrett's related esophageal adenocarcinoma cells.
Sriramajayam K; Peng D; Lu H; Zhou S; Bhat N; McDonald OG; Que J; Zaika A; El-Rifai W
Redox Biol; 2021 Jul; 43():101970. PubMed ID: 33887608
[TBL] [Abstract][Full Text] [Related]
5. Activation of EGFR-DNA-PKcs pathway by IGFBP2 protects esophageal adenocarcinoma cells from acidic bile salts-induced DNA damage.
Zhou Z; Lu H; Zhu S; Gomaa A; Chen Z; Yan J; Washington K; El-Rifai W; Dang C; Peng D
J Exp Clin Cancer Res; 2019 Jan; 38(1):13. PubMed ID: 30626422
[TBL] [Abstract][Full Text] [Related]
6. APE1-mediated DNA damage repair provides survival advantage for esophageal adenocarcinoma cells in response to acidic bile salts.
Hong J; Chen Z; Peng D; Zaika A; Revetta F; Washington MK; Belkhiri A; El-Rifai W
Oncotarget; 2016 Mar; 7(13):16688-702. PubMed ID: 26934647
[TBL] [Abstract][Full Text] [Related]
7. Bile acid exposure up-regulates tuberous sclerosis complex 1/mammalian target of rapamycin pathway in Barrett's-associated esophageal adenocarcinoma.
Yen CJ; Izzo JG; Lee DF; Guha S; Wei Y; Wu TT; Chen CT; Kuo HP; Hsu JM; Sun HL; Chou CK; Buttar NS; Wang KK; Huang P; Ajani J; Hung MC
Cancer Res; 2008 Apr; 68(8):2632-40. PubMed ID: 18413730
[TBL] [Abstract][Full Text] [Related]
8. In Barrett's epithelial cells, weakly acidic bile salt solutions cause oxidative DNA damage with response and repair mediated by p38.
Huo X; Dunbar KB; Zhang X; Zhang Q; Spechler SJ; Souza RF
Am J Physiol Gastrointest Liver Physiol; 2020 Mar; 318(3):G464-G478. PubMed ID: 31984785
[TBL] [Abstract][Full Text] [Related]
9. Impact of APE1/Ref-1 redox inhibition on pancreatic tumor growth.
Fishel ML; Jiang Y; Rajeshkumar NV; Scandura G; Sinn AL; He Y; Shen C; Jones DR; Pollok KE; Ivan M; Maitra A; Kelley MR
Mol Cancer Ther; 2011 Sep; 10(9):1698-708. PubMed ID: 21700832
[TBL] [Abstract][Full Text] [Related]
10. Apurinic/Apyrimidinic Endonuclease 1/Redox Factor-1 (Ape1/Ref-1) Modulates Antigen Presenting Cell-mediated T Helper Cell Type 1 Responses.
Akhter N; Takeda Y; Nara H; Araki A; Ishii N; Asao N; Asao H
J Biol Chem; 2016 Nov; 291(45):23672-23680. PubMed ID: 27637330
[TBL] [Abstract][Full Text] [Related]
11. Specific inhibition of the redox activity of ape1/ref-1 by e3330 blocks tnf-α-induced activation of IL-8 production in liver cancer cell lines.
Cesaratto L; Codarin E; Vascotto C; Leonardi A; Kelley MR; Tiribelli C; Tell G
PLoS One; 2013; 8(8):e70909. PubMed ID: 23967134
[TBL] [Abstract][Full Text] [Related]
12. Suppression of choroidal neovascularization through inhibition of APE1/Ref-1 redox activity.
Li Y; Liu X; Zhou T; Kelley MR; Edwards PA; Gao H; Qiao X
Invest Ophthalmol Vis Sci; 2014 Jun; 55(7):4461-9. PubMed ID: 24970265
[TBL] [Abstract][Full Text] [Related]
13. Antitumor Activity and Mechanistic Characterization of APE1/Ref-1 Inhibitors in Bladder Cancer.
Fishel ML; Xia H; McGeown J; McIlwain DW; Elbanna M; Craft AA; Kaimakliotis HZ; Sandusky GE; Zhang C; Pili R; Kelley MR; Jerde TJ
Mol Cancer Ther; 2019 Nov; 18(11):1947-1960. PubMed ID: 31413178
[TBL] [Abstract][Full Text] [Related]
14. Bile acids induce overexpression of homeobox gene CDX-2 and vascular endothelial growth factor (VEGF) in human Barrett's esophageal mucosa and adenocarcinoma cell line.
Burnat G; Rau T; Elshimi E; Hahn EG; Konturek PC
Scand J Gastroenterol; 2007 Dec; 42(12):1460-5. PubMed ID: 17852856
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of the redox function of APE1/Ref-1 in myeloid leukemia cell lines results in a hypersensitive response to retinoic acid-induced differentiation and apoptosis.
Fishel ML; Colvin ES; Luo M; Kelley MR; Robertson KA
Exp Hematol; 2010 Dec; 38(12):1178-88. PubMed ID: 20826193
[TBL] [Abstract][Full Text] [Related]
16. Gene expression changes associated with Barrett's esophagus and Barrett's-associated adenocarcinoma cell lines after acid or bile salt exposure.
Hao Y; Sood S; Triadafilopoulos G; Kim JH; Wang Z; Sahbaie P; Omary MB; Lowe AW
BMC Gastroenterol; 2007 Jun; 7():24. PubMed ID: 17597535
[TBL] [Abstract][Full Text] [Related]
17. APE1/Ref-1 prevents oxidative inactivation of ERK for G1-to-S progression following lead acetate exposure.
Wang YT; Tzeng DW; Wang CY; Hong JY; Yang JL
Toxicology; 2013 Mar; 305():120-9. PubMed ID: 23370007
[TBL] [Abstract][Full Text] [Related]
18. Small-molecule inhibitor of the AP endonuclease 1/REF-1 E3330 inhibits pancreatic cancer cell growth and migration.
Zou GM; Maitra A
Mol Cancer Ther; 2008 Jul; 7(7):2012-21. PubMed ID: 18645011
[TBL] [Abstract][Full Text] [Related]
19. Activation of the interleukin-6/STAT3 antiapoptotic pathway in esophageal cells by bile acids and low pH: relevance to barrett's esophagus.
Dvorak K; Chavarria M; Payne CM; Ramsey L; Crowley-Weber C; Dvorakova B; Dvorak B; Bernstein H; Holubec H; Sampliner RE; Bernstein C; Prasad A; Green SB; Garewal H
Clin Cancer Res; 2007 Sep; 13(18 Pt 1):5305-13. PubMed ID: 17875759
[TBL] [Abstract][Full Text] [Related]
20. Bile acids increase levels of microRNAs 221 and 222, leading to degradation of CDX2 during esophageal carcinogenesis.
Matsuzaki J; Suzuki H; Tsugawa H; Watanabe M; Hossain S; Arai E; Saito Y; Sekine S; Akaike T; Kanai Y; Mukaisho K; Auwerx J; Hibi T
Gastroenterology; 2013 Dec; 145(6):1300-11. PubMed ID: 23933602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
